BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
22 hedge funds and large institutions have $6.7M invested in Bellicum Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$272K | |
| 2 | +$71.4K | |
| 3 | +$13.8K | |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$11.5K |
| 5 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$1K |
Top Sellers
| 1 | -$167K | |
| 2 | -$166K | |
| 3 | -$58K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$52K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$15.5K |